mrna
The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.
Peak volume
500+
First seen
2026-08-20
Last seen
2026-08-20
Days trending
1 / 1
Countries
5
The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.